Alnylam hails RNAi delivery tech as future of biz after PhI results Alnylam hails RNAi delivery tech as future of biz after PhI results 05-Jan-2012 By Nick Taylor Phase I data shows Alnylam a “very potent” RNAi delivery platform that can be the foundation of its future, the company’s CEO said.
Heart disease gene uncovered Heart disease gene uncovered 05-Mar-2004 Researchers in Finland and the US have identified a gene that predisposes people to one of the most common causes of coronary heart disease, raising the hope that it could represent a new target for drug treatment.